News Releases

News Releases

Keyword Search

Date Title  
12/13/21
Optinose Announces Appointment of Two New Members to Board of Directors
Printer Friendly Version
11/23/21
Optinose to Present at the Piper Sandler Virtual Healthcare Conference
Printer Friendly Version
11/18/21
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Printer Friendly Version
11/18/21
Optinose Announces Closing of $46.0 Million Public Offering of Common Stock
Printer Friendly Version
11/16/21
Optinose Announces Pricing of Public Offering of Common Stock
Printer Friendly Version
11/15/21
Optinose Announces Proposed Public Offering of Common Stock
Printer Friendly Version
11/15/21
Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
Printer Friendly Version
11/10/21
Optinose Announces Reporting Date for Third Quarter 2021 Financial Results
Printer Friendly Version
10/28/21
Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis
Printer Friendly Version
09/22/21
Optinose to Present at the Cantor Virtual Global Healthcare Conference
Printer Friendly Version
08/25/21
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Printer Friendly Version
08/11/21
Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights
Printer Friendly Version
07/30/21
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis
Printer Friendly Version
07/28/21
Optinose Announces Preliminary Second Quarter 2021 XHANCE Net Revenue of $18.4 Million
Printer Friendly Version
06/24/21
Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry
Printer Friendly Version
06/02/21
Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps That Highlights Role of XHANCE® In Stepwise Care
Printer Friendly Version
06/01/21
Optinose to Present at the Jefferies Virtual Healthcare Conference
Printer Friendly Version
05/05/21
Optinose Reports First Quarter 2021 Financial Results and Operational Updates
Printer Friendly Version
04/28/21
Optinose Announces Reporting Date for First Quarter 2021 Financial Results and Upcoming Healthcare Conference Presentation
Printer Friendly Version
04/27/21
New Harris Survey Reveals Chronic Nasal Congestion Is Surprisingly Widespread: Nearly 1 in 4 Americans With Nasal Congestion Experience Symptoms Almost Every Day
Printer Friendly Version
04/12/21
Optinose to Present at the Needham Virtual Healthcare Conference
Printer Friendly Version
03/03/21
Optinose Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
Printer Friendly Version
02/17/21
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
Printer Friendly Version
01/25/21
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Printer Friendly Version

Investors


Toolkit